WebMar 22, 2024 · Those efforts have included the licensing of a specific synthetic platelet technology from the Sen Gupta lab: SynthoPlate, by Haima Therapeutics, a biotechnology company Sen Gupta co-founded in 2016. The new NIH-funded work builds on the prior research to create an artificial platelet system that can generate and stabilize fibrin , a … Web3910791. Contact Us About The Company Profile For Haima Therapeutics LLC. CHRISTA PAWLOWSKI ( ASSOCIATE) RT BIOTECH CONSULTING LLC. OHIO DOMESTIC LIMITED-LIABILITY COMPANY. WRITE REVIEW. Address: …
Haima Therapeutics Receives Phase II TVSF Award from the State …
WebPostdoctoral Fellow at Haima Therapeutics LLC . Job Description . Haima Therapeutics is a small pre-clinical stage biotechnology company located in Cleveland, OH focused on developing bio-inspired therapies for the treatment of bleeding and other blood-related pathologies. We are commercializing a platelet inspired novel, nanoparticle-based ... WebHaima Therapeutics LLC * 2 Principals See who the company's key decision makers are 5 Contacts Reach the right people with access to detailed contact information. 9 See … idsa staph bacteremia
SynthoPlate: Intravenous Hemostatic Nanotechnology to Mitigate …
WebPrior to joining Allinaire, Dr. Pawlowski co-founded Haima Therapeutics, LLC, a biotechnology company focused on the development of a novel artificial platelet therapy … WebSatish was a co-founder and CEO of NeoGenesis (acquired by Schering-Plough, now Merck), Co-founder and President of Verastem (NADAQ: VSTM) and co-founder of Elicio Therapeutics. He also served as Vice President and Site Head at Schering-Plough Research Institute in Cambridge, Massachusetts, and Vice President at Bristol-Myers … WebNov 13, 2024 · Platelets are primarily responsible for staunching bleeding by forming a 'platelet plug' and further amplifying thrombin generation on its surface to facilitate fibrin formation, leading to hemostatic clot formation at the site of vascular breach. idsa society awards